Home / Companies / News / India lifts curbs on exports of 13 active pharmaceutical ingredients

India lifts curbs on exports of 13 active pharmaceutical ingredients

In the first week of March, India restricted the exports of 13 APIs and their formulations to ensure there was no shortage in the domestic market.

Premium

A leading exporter said: “There is enough stock of paracetamol in the country. At present, the US, which has become the epicenter of the Covid-19 outbreak, needs paracetamol.

Sohini Das Mumbai

2 min read Last Updated : Apr 07 2020 | 1:48 AM IST

Amid growing pressure from countries like the US and easing supplies from China, India on Monday lifted the curbs on exports of 13 active pharmaceutical ingredients (APIs) and their formulations. Sources claim the ban on exports of hydroxychloroquine (HCQ) claimed to be effective to treat coronavirus may also be lifted.

“Exports were banned given the shortage of raw material in the country that could have, in turn, led to a crisis in the home market, especially for key drugs like paracetamol. The APIs for these drugs primarily came from Hubei province. But now the supplies have eased,” said an official.

Topics : Coronavirus Indian pharma companies Indian Pharmaceuticals Industry drug export

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in